FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TACLONEX, the fixed-dose combination of calcipotriene and betamethasone dipropionate, submitted by LEO Pharma In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• TACLONEX (calcipotriol and betamethone dipropionate)

Snippet

SUPPL AP for TACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)